A series of high-pressure liquid chromatographic (hplc) procedures are described for the separation of all major and most minor catecholamine metabolites present in human urine. The amines and metabolites are first concentrated and partially purified by traditional methods, ion-exchange and alumina chromatography. Final separations are then performed with hplc. Our system is specifically designed to study dopamine Phydroxylation in vivo.
Dopamine /3-hydroxylase (EC 1.14.17.1; 3,4-dihydroxyphenylethylamine, ascorbate: oxygen oxidoreductase) (DBH)' catalyzes the last step in NE biosynthesis (1) and is found mainly in catecholamine-containing tissues, such as sympathetic neurons, brain, and adrenal medulla (2,3). In noradrenergic neurons DBH is concentrated along with NE in the dense core vesicle of the nerve terminal and then released simultaneously with the neurotransmitter by a process of exo-1 To whom correspondence should be sent: Temple University Hospital, General Clinical Research Center, 3401 N. Broad St., Philadelphia, Pa. 19140 . * Abbreviations used: hplc, high-pressure liquid chromatography; THO, tritiated water; DBH, dopamine phydroxylase; NE, norepinephrine; NMN, normetanephrine; EPI, epinephrine; DA, dopamine; MN, metanephrine; MTA, methoxytyramine; DHPG, dihydroxyphenylglycol; DHPE, dihydroxyphenylethanol; DHMA, dihydroxymandelic acid; DOPAC, dihydroxyphenylacetic acid; MHPG, 3-methoxy-4-hydroxyphenylglycol: MHPE, 3-methoxy-4-hydroxyphenylethanal; VMA, 3-methoxy-4-hydroxymandelic acid; HVA, 3-methoxy-4-hydroxyphenylacetic acid.
cytosis (4). The limited tissue distribution of DBH has important implications for quantitative studies of dopamine p-hydroxylation in viva. Since systemically given catecholamines are not well taken up into the brain (5), any dopamine P-hydroxylation which occurs following [3H]DA administration to the whole patient must derive from that small fraction of the [3HlDA which gains access to sympathetic neurons and adrenal medulla. Accordingly, a relatively low rate of dopamine /3-hydroxylation would be anticipated following the administration of this substrate to whole animals or humans. Presumably for this reason, some studies of dopamine metabolism in rats, guinea pigs, and dogs (6.7) have ignored the small pool of dopamine molecules which undergo P-hydroxylation.
Quantitation of the rate of dopamine P-hydroxylation in viva has been a technically difficult problem in the past because of difficulties encountered in measuring the small 1 . Flow sheet for the separation of catecholamines and catecholamine metabolites. After the urine samples had been passed over Dowex 5OW-X4 and alumina, 50-ml aliquots were subjected to enzymatic hydrolysis and then recycled through Dowex 5OW-X4 and alumina for the assay of the conjugated deaminated catechols (DHPG, DHPE, DHMA, and DOPAC) and the total O-methylated deaminated metabolites (MHPG, MHPE, VMA, and HVA). Conjugated amines (NE, NMN, DA, and MTA) were assayed in separate aliquots of urine that were subjected to acid hydrolysis prior to Dowex SOW-X4 adsorption and elution was performed just as outlined for the free amines.
pool of NE metabolites in the presence of the much larger pool of excreted DA metabolites. With the recent development of hplc, however @-IO), it is now possible to separate these two major families of catecholamine metabolites with relative ease. This is because the presence of a hydroxyl group on the P-position of these molecules significantly increases polarity and dramatically decreases hplc retention times. In this report, we describe a chromatographic system which combines hplc with standard techniques (ion-exchange and alumina chromatography) and effectively separates all major and most minor catecholamine metabolites (Fig. 1 leads to the formation of THO. In rats the rate at which THO is released from this substrate in rive can be used as an index of dopamine P-hydroxylation in the whole animal (11). We, thus, chose P-labeled DA for the present studies since we hope in the future to see whether the tritium release principle developed in rats can be employed as an in ttitw assay of the human enzyme as well.
jects remained upright and ambulatory during the urine collection period, though they were allowed to sit down for lunch and a 5-min rest period each hour was allowed for those who needed it. The patients ingested a regular diet. Cigarette smoking was not allowed. Separation of 3H-catecholamines and 3H-O-methylated amines. The labeled amines were extracted from the urine with Dowex 5OW-X4 in the hydrogen form. Ascorbic acid (0.2 ml of 2% solution) and disodium EDTA (1 .O ml of a 2% solution) were added to 48-ml aliquots of urine immediately prior to their analysis. The urine was adjusted to pH 6.5 and filtered through Whatman No. 1 paper and the loss of volume was recorded. The sample was then divided into two equal portions each of which was then passed over a 0.7 x 4.5-cm Dowex SOW-X4 column. Partial fractionation of the amines was achieved by eluting the columns with increasing concentrations of HCl according to the method of Taylor and Laverty (12) .
The 1 N HCl fractions from the duplicate Dowex columns were pooled (total volume 20 ml) and the t3H]NE was concentrated by passing this eluate over a 0.7 x 1.5~cm alumina column. The 3H-catecholamines were eluted with 0.2 N acetic acid (final volume 3.5 ml). The [3H]NE was then separated from the [p-3H]DA by hplc.
The 2 N HCl fractions from the duplicate Dowex columns were also pooled (total volumes 25 ml) and the [3H]NMN was concentrated by passing this eluate over a second Dowex column. The 1 N HCl fraction of the second column was discarded, and then [3H]-NMN and [/3-3HlDA were eluted with 6.5 ml of 4 N HCl. The 3H-amines in this fraction were then separated by hplc.
The conjugated amines were assayed in separate aliquots of urine from which the free 3H-catecholamines were first removed by passage over alumina. The alumina tiltrates were then subjected to acid hydrolysis under the conditions previously described (13). The conjugated 3H-catecholamines sulfonate (60 mg/liter) was used as the paired (now present as free compounds) were then ion reagent. After the DHPG had eluted, extracted by the Dowex 5OW-X4 columns the buffer was made 16% with respect to as described above for the unhydrolyzed methanol. Flow rate of the mobile phase samples. The rate of excretion of the 3H-was 0.8 ml/min. Retention times were deconjugated 0-methylated amines could be termined by adding standard compounds and calculated by subtracting the rate of excrethen simultaneously monitoring optical tion of the free compounds (as measured in density and collecting fractions for radioacthe unhydrolyzed samples) from the rate of tivity determination as described for the excretion in the free and conjugated O-methamines. ylated amines (as measured in the hydrolyzed The 0.25 N HCl fraction was subjected samples).
to hplc in 0.01 M H3P04 containing 20 mg Reversed-phase hplc of the amine fracof tetraheptylammonium chloride as a paired tions was performed after equilibration of ion reagent. The flow rate of the mobile the columns with potassium monophosphate phase was 0.6 ml/min. After the DHMA had buffer (0.05 M) containing 5% methanol and eluted, we made the mobile phase 20% with 60 mg/liter of sodium octyl sulfonate as a respect to methanol (to hasten the elution paired ion reagent (9). Mobile-phase flow of the DA metabolites). rate was 0.8 ml/min, and loo-p.1 aliquots Separation of 0-methylated deaminated were used for all analyses. Retention times metabolites.
Urine which had been passed were determined by adding standard amines over Dowex 5OW-X4 (which removed the (0.10-0.30 mg/ml) to the samples, and moni-3H-amines) and alumina (which removed 3H-toring ultraviolet absorbance at 254 nm. We catechols) was used for the assay of neutral simultaneously collected 30-s fractions, and and acidic 0-methylated metabolites (VMA, assayed the 3H-amines by liquid scintillation HVA, MHPG, MHPE). Aliquots of the spectrophotometry (Beckman LS-250). With alumina effluents (23 ml) were adjusted to older columns retention times could be impH 1.0 with 6 N HCl, and then the sample proved by using trichloroacetic acid (0.04 was transferred to a 50-ml glass-stoppered M) as the paired ion reagent as suggested centrifuge tube, saturated with solid NaCl, by Freed and Asmus (10).
and an equal volume of ethyl acetate was Separation of deaminated catechols. The added. After mechanical shaking for 10 min, neutral and acidic catechol metabolites the samples were centrifuged (SOOOg, 10 (DHPG, DHPE, DHMA, and DOPAC) were min) and the organic phase was transferred extracted from pooled effluents of the Dowex to a second set of tubes. The process was 5OW-X4 columns (total volume 60 ml) by repeated with a second portion of ethyl aceabsorption at pH 8.6 onto alumina columns tate, and the organic phases from the two (0.7 x 3.0 cm). After an g-ml H,O wash, extractions were combined. Back extraction the neutral catechols (DHPG and DHPE) was performed by mechanically shaking the were eluted with 5.5 ml of 0.2 N acetic acid, pooled organic phases for 10 min with 4 ml and then the acidic catechols (DHMA and of 2.5 N NH,OH.
The organic phase was DOPAC) were eluted with 5.5 ml of 0.25 discarded, and most of the NH, was removed N HCI (14) . from the aqueous phase by allowing it to The 0.2 acetic acid fraction was subjected stand 24 h under a hood at room temperato reversed-phase hplc following preequiliture. The sample was then adjusted to pH bration with 0.025 M potassium monophos-4.5 with 1 N HCl and the alteration in volphate buffer, pH 4.75, containing citric acid ume recorded. Aliquots (100 ~1) of these (0.01 M) and 6% methanol. Sodium heptyl samples were analyzed by a hplc system utilizing 0.025 M potassium monophosphate buffer containing 0.01 M citric acid and 60 mg sodium heptylsulfonate per liter. The buffer was adjusted to pH 4.0 with 1 N NaOH. The initial methanol concentration was 12%; this was stepped up to 25% after the VMA and MHPG had eluted.
Enzymatic hydrolysis and the assay of conjugated rnetabolites. The remaining alumina effluent (that not used for the assay of free deaminated, O-methylated metabolites) was subjected to enzymatic hydrolysis with glusulase according to the method of Bigelow et al. (15) . Following precipitation of the phosphates and sulfates, the barium was removed by addition of saturated potassium carbonate as described by Shimizu and LaBrosse (16) . Following the enzymatic hydrolysis and precipitation of proteins (15), the samples were recycled through Dowex 5OW-X4 and alumina, just as described for the unhydrolyzed samples (see Fig. 1 ). We did not, however, elute the 3H-amines liberated in the enzymatic hydrolysis from the Dowex columns since these metabolites were assayed in separate aliquots of urine treated with acid hydrolysis as described above.4 The neutral and acidic deaminated 3H-catechols, excreted as conjugates but now present as free compounds, were determined in their respective alumina eluate fractions. Aliquots of the final alumina effluent were used for the assay of total All data are corrected for losses associated with the gravity chromatography.
Recoveries were determined by measuring the OD,,, of standards carried through the above separation techniques. The recovery of all the compounds studied ranged between 50 and 80%, except for NMN whose recovery ' We needed to employ both acid hydrolysis and enzymatic hydrolysis since the recovery of catecholamine is higher after acid hydrolysis than after the enzymatic treatment, whereas the reverse is true for MHPG (13, 15) . through the two Dowex columns averaged only 40%. No correlation was made for losses associated with the hplc. We assumed the enzymatic hydrolysis was 85% effective (16) and the acid hydrolysis was 100% effective.
RESULTS

Separation of 3H Catecholamines and 3H-O-Methylated Amines
The catecholamines and their O-methylated derivatives could be readily separated by a single hplc system using potassium monophosphate buffer (0.05 M) containing 5% methanol and sodium octylsulfonate (60 mg/liter) as a paired ion reagent (9) (Fig. 2) 
Separation of Deaminated Catechols
A mixture of standard neutral and acidic catechol metabolites (DHPG, DHPE, DHMA, and DOPAC) could be separated by a single hplc system (Fig. 3) (14). The 0.2 N acetic acid fraction was then analyzed by the neutral hplc system described above, and the 0.25 N HCl fraction was analyzed by an acidic hplc system (0.01 M H,PO, containing 20 mg of tetraheptylammonium chloride/ liter) which retained the [3H]DHMA sufficiently to separate it from the interfering peak which eluted earlier (Fig. 4) . Though this acidic system did not separate [3H]-DHPG from 13H]DHMA this was of no importance since the former eluted in the 0.2 N acetic acid fraction and minimal cross contamination of the 0.25 N HCl fraction occurred. Though the fractional elution of the alumina column effectively separated [3H]-DHPG from [3H]DHMA the corresponding [3HlDA metabolites,
[3H]DHPE and [3H]-DOPAC, were not reliably separated by this protocol, so it was necessary to measure these labeled metabolites in the 0.2 N acetic acid fraction as well as the 0.25 N HCl fraction (Fig. 1) .
Using this protocol we were able to identify free [3H]DHPG in five of seven samples; sample, and hplc was performed. ODzsa was monitored while fractions were collected for radioactivity determination. High-pressure liquid chromatography was performed with a mobile phase of 0.05 M potassium monophosphate buffer containing 5% methanol and sodium octylsulfonate as a paired ion reagent. The 2 N HCI Dowex SOW-X4 fractions from two columns were pooled and the 3H-amines concentrated by another Dowex SOW-X4 column. After washing this column with S ml of H,O and I4 ml of I N HCI, [3H]NMN and [p-3H]DA were eluted with 6.5 ml of 4 N HCI. High-pressure liquid chromatography was then performed as described for the 1 N HCI fractions. The 3 N HCI Dowex fractions were subjected directly to hplc. Neutral hplc system for separation 3H-deaminated catechols. Aliquots (100 ~1) of the 0.2 N acetic acid eluate of the alumina columns were subjected to hplc following preequilibration of the column with 0.025 M potassium phosphate buffer, pH 4.75, containing citric acid (0.01 M) and 6% methanol. Sodium heptylsulfonate (60 mg/liter) was used as the paired ion reagent. Flow rate of the mobile phase was 0.8 ml/min. After ["H]DHMA and t3H]DHPG had eluted the mobile phase was made 16% with respect to methanol.
following enzymatic hydrolysis of the alumina effluent and recycling of the sample through Dowex and alumina, hplc analysis of the 0.2 N acetic acid eluate revealed that a peak of radioactivity eluting with authentic DHPG could be identified in all seven samples.5 Free [3H]DHMA was also identified in all of our samples, but following enzymatic hydrolysis radioactivity coeluted with standard DHMA in only three of seven samples.
5 Conjugated DHPG is a known metabolite of NE in rat brain (17, 18) , and has recently been identified in human urine by a mass spectroscopic method (19).
Separation of 0-Methylated Deaminated Metabolites
The neutral and acidic 0-methylated metabolites (VMA, HVA, MHPG, and MHPE) were separated by hplc using 0.025 M potassium monophosphate buffer containing 0.01 M citric acid and 60 mg sodium heptylsulfonate per liter, pH 4.0, with an initial methanol concentration of 12% and a final methanol concentration of 25% (Fig. 5) . High-pressure liquid chromatographic separation of the 0-methylated deaminated metabolites. The 0-methylated deaminated metabolites were extracted from the Dowex 5W-X4 and alumina effluents by extraction into ethyl acetate from an acidic @H 1.0) salt saturated aqueous phases. Following back extraction with 2.5 N NHIOH (see Methods), the resulting aqueous phase, following neutralization, was subjected to hplc. The mobile phase was 0.025 M potassium phosphate buffer, pH 4.0, containing 0.01 M citric acid and 60 mg sodium heptylsulfonate per liter. The initial methanol concentration was 12%; after the 13H]VMA and L3H]MHPG had eluted, the mobile phase was made 25% with respect to methanol.
We found a radioactivity peak eluting with standard MHPG only in samples subjected to enzymatic hydrolysis, whereas [3H]VMA was identified in unhydrolyzed as well as hydrolyzed samples. We routinely assayed the [3H]VMA only in unhydrolyzed samples since incubation with glusulase did not increase the yield of this labeled metabolite. This finding is in disagreement with Goodall and Alton's report of a large (1.0% of administered radioactivity), labeled peak identified as conjugated [3H]VMA (20). In most of our samples, the amount of radioactivity eluting in fractions that would have contained C3H]MHPE was negligible. As anticipated from previous studies (6, 7, 20) 
DISCUSSION
There is little agreement in the existing literature on the rate at which systemically administered labeled dopamine undergoes P-hydroxylation in whole animals and human subjects. In a number of studies of dopamine metabolism, the pool of /3-hydroxylated metabolites has apparently been too small to be resolved by the chromatographic procedure employed (6,7). We estimated, however, in rats on the basis of a tritium release assay that the in vivo rate of dopamine /3-hydroxylation was 3.4 +-0.3%/10 min (11). Similarly, following the intravenous administration of labeled tyramine to rats, there is rapid accumulation of the labeled $-hydroxylated derivative octopamine in sympathetically innervated organs, such as heart and spleen (21). Similarly, another phenylethylamine DBH substrate, hydroxyamphetamine, readily undergoes in vivo /3-hydroxylation in man. Sjoerdsma and von Studnitz observed that following the oral administration of hydroxyamphetamine to humans, between 4 and 9% of the administered drug is converted over a 24-h period to the P-hydroxylated product, hydroxynorephedrine (22) .
The data in the present report do not agree well with a previous study of dopamine P-hydroxylation in man. Goodall and Alton reported that during the first 6 h following the administration of [14C]DA to humans, 8% of the administered isotope could be accounted for as excreted metabolites of . In the present study, however, we found that only 1.28 + 0.16% of the administered radioactivity was excreted in the [3H]NE metabolite pool during the first 6 h following the administration of isotope (Table 1) and the ratio of total [3H]NE metabolites/total
[3H]DA metabolites was 0.029 of: 0.005 (SEM). These estimates of [3H]NE metabolite excretion would be doubled if we had used a substrate whose label could not be released during the enzymatic hydroxylation.3
Even with this correction, however, our estimate of the rate of dopamine P-hydroxylation in vivo remains much lower than that reported by Goodall and Alton. Since higher degrees of resolution can be achieved with hplc than with traditional ion-exchange chromatography, our estimate of the [3H]NE metabolite pool is probably more accurate than that based on the older methodology.
We suspect, for example, that the large peak of radioactivity (1 .O% of administered isotope) identified as conjugated [3H]VMA represented some interfering compound since we were unable to even identify this metabolite in our chromatographic system. Alternatively, differences in experimental protocol may explain the discrepancy between our data and that reported by Goodall and Alton. We gave the dopamine over 2 min and these previous investigators administered it over 4 h as a constant infusion. Moreover, we used [3Hl-DA, whereas they used [14C]DA.
Since hplc retention time is dramatically altered by the polarity change caused by the presence of a hydroxyl group on the P-position of the catechol side chain, this technique is ideal for the separation of NE from DA metabolites. Yet our attempts to accurately quantitate the total [3H]NE metabolite pool has been complicated by the presence of a number of unidentified peaks of radioactivity whose low hplc retention times suggest a high degree of polarity possibly indicative of a hydroxyl group on the P-position of the molecule. In particular, the basis of the chromatographic behavior (rapid hplc elution) of the peak of radioactivity eluting just before [3H]DHMA (See Fig. 4 ) and the peak of radioactivity eluting just before [3H]VMA (see Fig. 5 
